Material Detail

"Clinical Care Options: Management of ER+ Postmenopausal Early Breast Cancer" icon

Clinical Care Options: Management of ER+ Postmenopausal Early Breast Cancer

In this management series on ER-Positive Postmenopausal Breast Cancer, expert faculty present compelling clinical data on the use of predictive factors for guiding treatment decisions, as well as therapeutic strategies and safety profiles associated with the use of tamoxifen and aromatase inhibitors. Virtual presentations include The Role of Predictive Factors in Guiding Treatment Decisions for ER-Positive Postmenopausal Breast Cancer, Current Hormonal Therapy Strategies for ER-Positive Postmenopausal Breast Cancer, Evaluating Long-Term Safety of Aromatase Inhibitors, and Treatment Options for an ER-Positive Postmenopausal Woman With Early Breast Cancer. Membership is required to access material; membership is free.
Rate

Quality

  • Editor Reviews
  • User Rating
  • Comments
  • Learning Exercises
  • Bookmark Collections
  • Course ePortfolios
  • Accessibility Info

More about this material

Comments

Log in to participate in the discussions or sign up if you are not already a MERLOT member.